Chronic cough is frustrating for patients and their families, especially during the pandemic, explained Krishna M. Sundar, MD, FCCP, clinical professor, Pulmonary Division, Department of Medicine, and medical director, Sleep-Wake Center, University of Utah.
Chronic cough is frustrating for both patients and their family members, especially during the pandemic, so there is a need for these patients to be appropriately evaluated and treated, explained Krishna M. Sundar, MD, FCCP, clinical professor, Pulmonary Division, the Department of Medicine, and medical director for the Sleep-Wake Center at the University of Utah, when discussing this year’s CHEST meeting.
Transcript
What will your talk on multispecialty management in unexplained chronic cough encompass?
I'm doing, I think, 1 of the 4 talks in that. So chronic cough is a pretty common problem in primary care and subspecialty clinics. These are patients that have been coughing for a few months or longer, and then there is something called chronic refractory cough. So most of the chronic cough patients get treated for acid reflux disease, asthma, and rhinosinusitis, any sinus problems. If they still persist with cough, then they undergo further investigated workups and further evaluation by specialists. Some of these patients have been coughing for decades, 5 years, 10 years, many years, and it’s frustrating for them and their family members, and especially during this COVID-19 [coronavirus disease 2019] period. Normally, everybody shies away from anybody who’s coughing. So, again, even before COVID-19 there was clearly a need for these cough patients to be appropriately evaluated and treated. So beyond the routine therapies, look for a cause for cough, such as acid reflux or postnasal drip.
This session actually looks at therapies beyond the usual ones that have been shown to be of some benefit. So one of the sessions, it’s on behavioral speech therapy, which looks at working the laryngeal function in these patients to see if it improves cough. My talk looks at management of comorbid sleep apnea, so they have coexisting sleep apnea. Sleep apnea is an extremely common problem, and there is a prevalence, again, a significant prevalence. Again, at least a third of these patients may have sleep apnea. And if we can treat that, there seems to be a benefit in terms of cough.
So my portion is dedicated to the role of treating coexisting sleep apnea in these patients and looking at the science behind it to see why it may be effective in these patients.
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More